Related Experiment Video
Updated: Aug 2, 2026
07:49
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
Neuroimmunoregulation and cancer (review)
1Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, R3E 0W3, Canada.
International Journal of Oncology
|October 17, 1998
Summary
Hormonal manipulation can enhance the body's natural and adaptive immune defenses against cancer. Combining hormonal stimulation with existing immunotherapies may offer a powerful approach for cancer treatment.
Area of Science:
- Oncology
- Immunology
- Endocrinology
Background:
- Neuroimmune mechanisms are crucial in cancer defense, but the interaction is complex and varies with neoplasm type.
- Adaptive immunity is present in many tumor-bearing hosts and can be enhanced by vaccines and cytokines.
- Natural immune mediators also contribute to tumor resistance.
Purpose of the Study:
- To review evidence on how hormonal manipulation can bolster host immune defenses against cancer.
- To explore the potential of combining hormonal stimulation with conventional immunostimulants for cancer immunotherapy.
Main Methods:
- Review of existing evidence on neuroimmune interactions in cancer.
- Analysis of hormonal influences on adaptive and natural immunity.
- Consideration of cytokine and hormone roles in the acute phase response.
Main Results:
- Hormonal manipulation strengthens both adaptive and natural immune defenses against cancer.
- Cytokines and hormones elevate natural defense mechanisms during acute phase responses (e.g., fever).
Conclusions:
- Hormonal stimulation of immune mechanisms, combined with standard immunostimulants, shows promise for combination cancer immunotherapy.
- Molecular biology techniques enable laboratory monitoring for predicting and tracking therapeutic success in cancer treatment.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...